All In Biotech

Drug Trial Radar · NCT00170989

Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Comparison of the Combination of Valsartan 320 mg Plus Hydrochlorothiazide 12.5 mg and Valsartan 320 mg Plus Hydrochlorothiazide 25 mg to Valsartan 320 mg in Mild to Moderate Hypertensive Patients Not Adequately Controlled With Valsartan 320 mg

Last checked: Nov 20, 2026Latest source record: Nov 8, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 2,714 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,714

Actual

Start

Sep 2004

Primary completion

Jul 2005

Study completion Jul 2005

Sponsor

Lead sponsor
NovartisNovartis (NVS)
Sponsor type
Industry
First posted
Sep 15, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years

Summary

As written by the sponsor on the registry.

This study will test the effectiveness and safety of a combination treatment in patients whose blood pressure is not controlled with a single medication.

Conditions

  • Hypertension

Interventions

  • valsartan plus hydrochlorothiazideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in diastolic blood pressure from baseline after 8 weeks

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Site not named

    Investigative Centers, Germany

  • Novartis Pharmaceuticals

    Basel, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.